We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Testing the Re-Engineered Hospital Discharge

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00252057
First Posted: November 11, 2005
Last Update Posted: March 28, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Brian Jack, Boston University
Results First Submitted: February 10, 2009  
Study Type: Interventional
Study Design: Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: Single (Outcomes Assessor);   Primary Purpose: Prevention
Condition: All
Intervention: Behavioral: Re-Engineered Hospital Discharge

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
All participants were recruited between January 1, 2006 and October 16, 2007, from the general medical floors at Boston Medical Center.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
The baseline interview was conducted after enrollment and prior to group assignment, but it did not affect this assignment or lead to exclusion from the study for any participant. All participants who gave consent and agreed to be in the study were assigned to a group

Reporting Groups
  Description
Re-engineered Hospital Discharge Participants received the "Re-Engineered Hospital Discharge", a set of 11 discrete, mutually reinforcing components provided by a Discharge Advocate and re-enforced by a telephone call 2-4 days after discharge by a clinical pharmacist.
Standard Hospital Discharge Participants received the routine, standard hospital discharge.

Participant Flow:   Overall Study
    Re-engineered Hospital Discharge   Standard Hospital Discharge
STARTED   373   376 
COMPLETED   370   368 
NOT COMPLETED   3   8 
Withdrawal by Subject                2                5 
Death                1                2 
Participant previously enrolled                0                1 



  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
Re-engineered Hospital Discharge Participants received the "Re-Engineered Hospital Discharge", a set of 11 discrete, mutually reinforcing components provided by a Discharge Advocate and re-enforced by a telephone call 2-4 days after discharge by a clinical pharmacist.
Standard Hospital Discharge Participants received the routine, standard hospital discharge.
Total Total of all reporting groups

Baseline Measures
   Re-engineered Hospital Discharge   Standard Hospital Discharge   Total 
Overall Participants Analyzed 
[Units: Participants]
 373   376   749 
Age 
[Units: Participants]
Count of Participants
     
<=18 years      0   0.0%      0   0.0%      0   0.0% 
Between 18 and 65 years      312  83.6%      314  83.5%      626  83.6% 
>=65 years      61  16.4%      62  16.5%      123  16.4% 
Age 
[Units: Years]
Mean (Standard Deviation)
 50.1  (15.1)   49.6  (15.3)   49.9  (15.2) 
Sex: Female, Male 
[Units: Participants]
Count of Participants
     
Female      178  47.7%      199  52.9%      377  50.3% 
Male      195  52.3%      177  47.1%      372  49.7% 
Region of Enrollment 
[Units: Participants]
     
United States   373   376   749 


  Outcome Measures

1.  Primary:   Total Number of Rehospitalizations (Emergency Department Visits Plus Hospital Admissions) in the 30 Days After Discharge.   [ Time Frame: 30 days after discharge ]


  Serious Adverse Events
  Hide Serious Adverse Events

Time Frame No text entered.
Additional Description No text entered.

Reporting Groups
  Description
Re-engineered Hospital Discharge Participants received the "Re-Engineered Hospital Discharge", a set of 11 discrete, mutually reinforcing components provided by a Discharge Advocate and re-enforced by a telephone call 2-4 days after discharge by a clinical pharmacist.
Standard Hospital Discharge Participants received the routine, standard hospital discharge.

Serious Adverse Events
    Re-engineered Hospital Discharge   Standard Hospital Discharge
Total, Serious Adverse Events     
# participants affected / at risk   0/373 (0.00%)   0/376 (0.00%) 




  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.


  More Information